MedTrace Logo

Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis

NCT02271204 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2014-10-22

No results posted yet for this study

Summary

This observational study assess the safety of intravenous Ibandronate (Bonviva) intermittent administration in patients with postmenopausal osteoporosis and the efficacy of IV Ibandronate (Bonviva treatment through relative lumbar spine and hip bone mineral densitometry form baseline at year 1)

Conditions

Interventions

DRUG

Ibandronic acid

As prescribed by physician

Sponsors & Collaborators

  • Clinic for Orthopedic Surgery, Skopje

    collaborator UNKNOWN

  • General Hospital, Kumanovo

    collaborator UNKNOWN

  • General Hospital, Struga

    collaborator UNKNOWN

  • Medical Faculty, Institute for Epidemiology and Biostatistics, Skopje

    collaborator UNKNOWN

  • Clinic of Endocrinology and Metabolic Disorders, Macedonia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2013-04-30
Completion
2014-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02271204 on ClinicalTrials.gov